{
  "catalogId": "87b4c14a-29d2-4742-9b9c-aa793fbbd236",
  "name": "IMATINIB - TRIMA 100 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "157 59 34527 00",
  "treatmentDescriptions": "Imatinib - Trima is indicated for the• Treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase, accelerated phase or blast crisis.• Treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST). • Adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive GIST.• Treatment of adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. • Treatment of adult patients with relapsed or refractory Ph+ ALL as monotherapy. • Treatment of adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery.• Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor) gene re-arrangements. • Treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL) who have the FIP1L1-PDGFRα fusion kinase (mutational analysis or FISH demonstration of CHIC2 allele deletion) and for patients with HES and/or CEL who are FIP1L1- PDGFRα fusion kinase negative. • Treatment of adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-kit mutation.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "IMATINIB AS MESYLATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE01",
      "name": "IMATINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "IMATINIB - TRIMA 100 MG  60 TAB",
      "manufacturer": {
        "name": "תרימה",
        "countryOfOrigin": "IL"
      },
      "strength": [
        {
          "value": 100.0,
          "unit": "mg"
        }
      ],
      "quantity": {
        "value": 60.0,
        "unit": "units"
      },
      "packagingDescription": "BLISTER PVC/ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8435",
        "yarpa": "49970",
        "pharmasoft": "10575"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 2830.2041,
        "retailMargin": 10.0,
        "maxRetailPrice": 3113.22451,
        "maxPriceWithVAT": 3673.604922
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.796545",
    "tags": [],
    "smartValidation": {
      "extractedFrom": "IMATINIB - TRIMA 100 MG  60 TAB",
      "processedBy": "smart_validation",
      "matchScore": 0.8333333333333334,
      "status": "corrected",
      "correctedAt": "2025-08-01T17:30:51.437277",
      "previousRegistration": "157 59 34527 00",
      "newRegistration": "157 59 34527 00",
      "apiSource": "IMATINIB - TRIMA 100 MG"
    }
  },
  "nameHebrew": "אימטיניב - תרימה 100 מ\"ג",
  "registrationDate": "2021-11-30"
}